Autopsy report · NCT04642287
Immunotherapy After Transplantation for Skin Cancer Prevention in Organ Transplant Recipients
Cause of deathFunding or business
“The study was withdrawn due to lack of financial support.”
Life of this trial
- Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.
Vital statistics
- Status
- Withdrawn
- Phase
- Phase 2
- Sponsor
- Massachusetts General Hospital
- Sponsor type
- University, hospital or other
- Conditions
- Immunotherapy; Cutaneous Squamous Cell Carcinoma; Actinic Keratoses; Organ Transplant Recipients; Skin Cancer
- Interventions
- Calcipotriol Only Product in Cutaneous Dose Form; Vaseline; Topical 5FU
- Participants
- 0
- Sites
- 2
- Countries
- United States
Trials that died the same way
- Bexarotene and Fenretinide as Addition to Antipsychotic Treatment in Schizophrenia Patients
“The study withdrawn due to lack financial support” - The Acute Cardiovascular Effects of Nicotine in E-cigarettes (ACE) Study
“Study discontinued due to lack of study funding.” - Aezea® (Cenersen) and Chemotherapy for AML Subjects ≥ 55 Years of Age With No Response to Frontline Induction Course
“Study Was Terminated due to lack of Funding.” - Characteristic Analysis and Surgical Exploration for Acetabular Roof Fractures: Multicenter Retrospective Cohort Study
“Due to limited funding, the study is now being withdrawn.” - Dim Light at Night in Patients With Obstructive Sleep Apnea
“The study was stopped due to lack of funding.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.